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AbstRACt
background: Labor is generally considered to be a very painful experience. Epidural analgesia which is the gold standard 
for labor pain relief is not widely available, affordable, or feasible, especially in our environment. Parenteral opioid analgesics, 
which are more commonly used, can cause nausea and vomiting in the patient and respiratory depression in the neonate; 
hence, they cannot be used in all stages of labor. There is thus the need for an alternative analgesic with similar or superior 
analgesic effect to opioids but without their fetomaternal side effects.
Objectives: The objective of this study was to compare the efficacy of intramuscular (IM) pentazocine and intravenous (IV) 
paracetamol infusion in relieving labor pain at Aminu Kano Teaching Hospital, Kano.
study Design: It was a randomized controlled study.
Methodology: One hundred women with singleton uncomplicated pregnancies and spontaneous labor at term were 
randomly assigned to the study group or control group. Women in the study group received an IV infusion of 1000 mg 
of paracetamol while women in the control group received a single dose of 30 mg of pentazocine intramuscularly. Labor 
pain perception was assessed using visual analog scale (VAS) scores at presentation and after delivery while maternal 
satisfaction assessed using Likert scale, and maternal and fetal complications were recorded after delivery. Statistical 
analysis was done using computer software SPSS Version 20.0. Chi‑square, Fisher’s exact test, t‑test, and Mann–Whitney 
U‑tests were used to compare means and proportions as appropriate for statistically significant differences, setting the 
level of significance (P value) at <0.05.
Results: There were no statistically significant differences between the two groups in their sociodemographic characteristics, 
obstetric characteristics, and labor characteristics. There was also no statistically significant difference in the VAS 
pain scores between the two groups before administration of the analgesics (P = 0.968) and after administration of the 
analgesics (P = 0.225). The maternal satisfaction with pain relief among the patients in the two groups was also found 
to be similar (P = 0.341). Nausea (P = 0.002), vomiting (P = 0.012), and drowsiness (P < 0.001) were significantly higher 
in the pentazocine group when compared with the paracetamol group. None of the patients in the two groups developed 
dyspnea during labor, skin rashes, or persistently low systolic blood pressure of <90 mmHg, and none had persistent fetal 
heart rate abnormalities during labor or appearance, pulse, grimace, activity, and respiration (APGAR) scrores <7 at the 
1st or 5th min after delivery. However, the mean APGAR 
score of the neonates at 1 min was significantly higher in 
the paracetamol group (P = 0.033), while there was no 
difference in the mean APGAR scores of the neonates in 
the two groups at 5 min after delivery (P = 0.152).
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Introduction
Labor is generally considered to be a very painful experience. 
Labor pain has been described as the worst pain that some 
women may experience in their lifetime. Majority of patients 
in developing countries do not receive any analgesia in labor. 
A study conducted in Maiduguri, on desire for pain relief in 
labor revealed that 81.6% of women would like pain relief in 
labor, but only 11% received analgesia, with 65.1% describing 
labor pain as severe.[1]
Pain results in physiologic effects as well as sensory and 
emotional responses. Labor pain which results in marked 
increase in minute ventilation and oxygen consumption 
during contractions, can cause severe respiratory alkalosis 
and a left shift of the maternal oxyhemoglobin dissociation 
curve, thus diminishing oxygen transfer to the fetus. 
Compensatory hypoventilation between contractions 
may cause transient maternal hypoxemia, and potentially, 
fetal hypoxemia. These periods of hypoventilation may be 
exacerbated by analgesic techniques that result in respiratory 
depression such as systemic opioid analgesia.[2] Pain during 
labor has also been correlated with the development of 
posttraumatic stress disorder.[3]
A wide range of methods for pain relief in labor have been 
described. Nonpharmacological interventions such as 
hypnosis, biofeedback, intracutaneous or subcutaneous 
sterile water injection, immersion in water, aromatherapy, 
relaxation techniques (yoga, music, audio), acupuncture 
or acupressure, manual methods (massage, reflexology), 
and transcutaneous electrical nerve stimulation primarily 
aim to help women cope with pain in labor, whereas the 
pharmacological interventions such as inhaled analgesia, 
opioids, nonopioid drugs, local anesthetic nerve blocks, 
epidural and intrathecal injections of local anesthetics, or 
opioids (or both) primarily aim to relieve the pain of labor.[4]
It has been proven that epidural analgesia, when compared 
with other methods, provides superior analgesia for labor.[5] 
However, it is not always feasible, affordable, or available, 
especially in our environment. Parenteral opioids are 
popularly used for labor pain relief. Pentazocine, an opioid 
analgesic, is the drug used for labor pain relief in our center. 
Opioids may cause nausea and vomiting and delayed gastric 
emptying which increases risk of aspiration should a general 
anesthetic be required in an emergency situation. All opioids 
cross the placenta. In utero, opioid exposure results in a 
slower fetal heart rate and decreased beat-to-beat variability. 
There is also a risk of neonatal respiratory depression as a 
result of which they cannot be administered in all stages of 
labor.[6] There is thus the need for an alternative analgesic with 
similar or superior analgesic effect to opioids but without 
their fetomaternal side effects.
Paracetamol is a nonopiate analgesic. Studies examining 
analgesic efficacy of paracetamol in obstetric cases such as 
abortion, postoperative pain after Caesarean delivery, and 
perineal pain after child birth have proposed that paracetamol 
is an effective analgesic.[7-10] Paracetamol infusion has been 
found to have comparable or superior analgesic efficacy 
to pethidine, tramadol, and placebo when used as a labor 
analgesic.[11-14] There is insufficient data in our environment 
looking at the efficacy and safety of intravenous (IV) 
paracetamol in relieving labor pain. The purpose of this study 
is to compare the efficacy of intramuscular (IM) pentazocine 
and IV paracetamol infusion in relieving labor pain at Aminu 
Kano Teaching Hospital, Kano. If the analgesic effect of IV 
paracetamol is found to be comparable or superior to that of 
pentazocine, then it can provide an opportunity to improve 
pain management in labor.
Methodology
This was a randomized controlled trial carried out at 
Aminu Kano Teaching Hospital, Kano, from November 2015 
to March 2016 after obtaining approval from the Research 
Ethics Committee of the hospital.
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Forty-four women were required in each group to achieve a 
power of 95% and Type 1 error of 0.05. To make up for those 
who could later be excluded from the study, 10% was added, 
giving a minimum sample size of 48. This was rounded up 
and 50 patients were recruited in each group. The data were 
collected over 5 months.
Conclusion: The analgesic efficacy of IV paracetamol was similar to that of IM pentazocine in labor, with similar levels of 
maternal satisfaction with pain relief, but IV paracetamol was associated with significantly lower rates of adverse effects.
Key words: Labor; pain relief; paracetamol; pentazocine.
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All pregnant women who presented with spontaneous onset 
of labor, a singleton live fetus at term in active phase of labor 
with cervical dilatation of 4–6 cm and consented to participate 
in the study were included in the study. The patients who 
were excluded were those who did not consent to participate 
and those who presented with preterm labor, multiple 
gestation, fetal heart rate abnormalities or intrauterine 
fetal death, previous caesarean section, fetal presentation 
other than cephalic as well as malposition of the fetal head, 
medical disorders including history of cardiac, liver and 
renal disease, history of hypersensitivity to pentazocine or 
paracetamol, complications such as antepartum hemorrhage, 
polyhydramnious, premature rupture of membranes, or use 
of any kind of analgesia before recruitment.
Sampling technique and randomization
A single-blind simple random sampling method was used 
in this study to recruit the subjects. Group A was the study 
group and the patients in that group received IV infusion 
of paracetamol. Group B was the control group and the 
patients in that group received IM pentazocine. Patients were 
assigned to either of the two groups by balloting. Two sets 
of 50 opaque envelopes containing pieces of paper labeled 
as A or B were prepared by a research assistant who did not 
participate in data collection. All 100 envelopes were mixed 
thoroughly and placed in a box in the labor ward. An envelope 
was given to each consecutive patient who consented and 
satisfied the inclusion criteria. The researcher did not know 
which group the patient belonged to before the end of the 
study.
Data collection techniques and tools
Eligible women who presented to the labor ward in labor 
were consecutively recruited into the study until the required 
sample size is obtained. The patients were recruited by the 
researcher and the two trained research assistants. The 
participants signed a written consent before participation. At 
the time of admission history was taken, antenatal records of 
the patient were reviewed, and clinical examination as well as 
a bed side ultrasound scan were done to exclude any of the 
exclusion criteria. Patients who fulfilled the inclusion criteria 
were recruited. The sociodemographic data (age, marital 
status, tribe, religion, occupation, and educational status) and 
obstetric data of the patients (parity, last menstrual period, 
estimated date of delivery, epidural-general anesthesia, 
use of analgesia in a previous pregnancy) were recorded 
in the questionnaire. The initial pain perception was also 
assessed using the VAS at admission before randomization 
and recorded in millimeters. All patients had IV access with a 
size 18 G cannula secured and artificial rupture of membranes 
done at admission if there was no contraindication. Patients 
were recruited in the admission room, then taken to the nurse 
in the delivery room who then did the randomization and 
drug administration. An envelope was opened by a nurse and 
the analgesic was administered. The nurse then recorded the 
patient’s serial number and group in a book that was provided 
and kept in the labor ward till the end of the data collection.
Patients in Group A (study group) received an IV infusion of 
1000 mg paracetamol in 100 ml solution over 15 min using 
a standard gravity-dependent IV infusion set, in which each 
20 drops give 1 ml (infusion rate was about 130 drops/min). 
At the same time, patients in Group B received 30 mg of IM 
pentazocine injection in the gluteal region. Only a single 
dose was used in both groups after randomization and repeat 
doses were not administered. A partograph was filled at 
admission for all patients, and monitoring was commenced 
20 min later to allow time for randomization and drug 
administration.
During the first stage of labor, the fetal heart rate was 
monitored using intermittent auscultation with a sonicaid 
every 15 min (during and immediately after uterine 
contractions). Persistent fetal heart rate abnormalities were 
defined in this study as the presence of fetal tachycardia 
(heart rate more than 160 beats/min) or bradycardia 
(heart rate <110 beats/min) or fetal heart rate decelerations 
lasting for more than 30 min.
Maternal vital signs were monitored hourly, uterine 
contractions were also monitored hourly, and pelvic 
examination was done 4 hourly. Fetal heart rate was 
monitored every 5 min in the second stage of labor with 
the same sonicaid. The third stage of labor was managed 
actively in all patients.
A resuscitation tray was made available in the labor ward 
containing naloxone, promethazine, IV fluids, syringes, 
and infusion giving sets. Furthermore, a neonatologist was 
to be present at delivery for neonatal resuscitation where 
persistent fetal heart rate abnormalities were found.
The severity of labor pain and maternal satisfaction with 
pain relief was assessed 1 h after delivery in both groups. 
Again, the severity of the labor pain was assessed using the 
VAS and the score recorded in millimeters, while maternal 
satisfaction with pain relief was assessed in both groups 
using the Likert scale. Appearance, pulse, grimace, activity, 
and respiration (APGAR) score of neonate in 1 and 5 min, 
presence of persistent fetal heart rate abnormalities during 
labor, and the duration of labor were also determined after 
delivery and recorded in the questionnaire. The incidence of 
maternal complications including nausea, vomiting, dyspnea, 
skin rash, and systolic blood pressure <90 mmHg were 
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recorded in each group 2 h after delivery. The researcher and 
four trained assistants (resident doctors in the Department of 
Obstetrics and Gynecology), all of whom did not know which 
drug was administered to the patient by the nurse, monitored 
the labor, and administered the questionnaire. The patients 
group was obtained from the record book and recorded on 
her questionnaire before data analysis.
All patients who eventually had augmentation of labor, 
instrumental delivery, or Caesarean section were to be 
excluded from the study, but all had normal vaginal delivery 
and none was excluded from the study.
Outcome measures
•	 Maternal:	Maternal	labor	pain	score,	maternal	satisfaction	
with pain relief, drowsiness during labor, nausea and 
vomiting in labor
•	 Fetal and neonatal: Persistent fetal heart rate abnormalities, 
APGAR score <7 at 1 min, and APGAR score <7 at 5 min.
Statistical analysis
Information obtained at the end of the study was processed 
using the SPSS 20.0 statistical program (IBM Corp. Released 
2011, IBM SPSS Statistics for Windows, Version 20.0 Armonk, 
NY, USA). Categorical data were expressed as frequencies and 
percentages and analyzed by Chi-square and Fisher’s exact 
tests. Normally distributed continuous data were described 
using mean and standard deviation and was analyzed using 
Student’s t-test, while continuous variables that were not 
normally distributed were analyzed using Mann–Whitney 
U-test. Paired t-test was used to analyze the difference 
in the mean VAS scores in each group before and after 
administration of the analgesic to determine whether the 
reduction in the pain score was statistically significant. The 
results were presented in tables. P < 0.05 was determined 
to be statistically significant.
Results
The study was carried out in the labor ward of Aminu Kano 
Teaching Hospital, Kano, from November 2015 to March 
2016. None of the patients was withdrawn from the study 
after recruitment, and all had vaginal deliveries. Relevant data 
were collected and analyzed in all the patients.
Table 1 shows the sociodemographic characteristics of the 
patients. The mean age of the patients in the study group 
was 26.9 ± 4.76 years while the mean age of patients in the 
control group was 27.1 ± 4.35 years, the difference was not 
statistically significant (P = 0.827). Generally, there were no 
statistically significant differences in the sociodemographic 
characteristics of the patients in the two groups.
Table 2 shows the obstetric and labor characteristics of the 
patients. There were no statistically significant differences 
between the two groups in terms of their obstetric and labor 
characteristics in this study.
Table 3 shows the pain perception scores of the patients 
and the maternal satisfaction with pain relief. The mean VAS 
scores at admission before administration of the analgesic 
was 97.5 ± 4.52 mm in the study group and 97.6 ± 5.28 mm 
in the control group, and these scores were statistically 
similar (P = 0.968). The mean VAS scores after administration 
of the analgesic was 77.6 ± 10.59 mm in the study group 
and 75.3 ± 9.84 mm in the control group, and these scores 
were also statistically similar (P = 0.225). In the study group, 
administration of IV paracetamol was associated with a 
reduction in the mean VAS pain score from 97.5 ± 4.52 
to 77.6 ± 10.59 mm, and this reduction in pain score was 
statistically significant (P < 0.001). Similarly, administration 
of IM pentazocine in the control group was associated with 
a reduction in the mean VAS pain score from 97.6 ± 5.28 
to 75.3 ± 9.84 mm and the difference was statistically 
significant (P < 0.001). The mean differences between the 
VAS scores before and after analgesic administration in 
the two groups were 19.0 ± 9.08 and 22.3 ± 8.48 mm in 
the study and control groups, respectively, and there was 
also no statistically significant difference between the two 
groups (P = 0.179).
Table 1: Sociodemographic characteristics of patients





Mean age±SD (years) 26.9±4.76 27.1±4.35 t=−0.22 0.827
Tribe, n (%)
Hausa 24 (48.0) 25 (50.0) χ2=2.46 0.653
Fulani 9 (18.0) 6 (12.0)
Yoruba 8 (16.0) 5 (10.0)
Igbo 6 (12.0) 10 (20.0)
Others* 3 (6.0) 4 (8.0)
Religion, n (%)
Islam 39 (78.0) 32 (64.0) χ2=2.38 0.123
Christianity 11 (22.0) 18 (36.0)
Occupation, n (%)
Housewife 21 (42.0) 23 (46.0) χ2=2.87 0.580
Trader/business 
woman
11 (22.0) 8 (16.0)
Teacher/lecturer 6 (12.0) 11 (22.0)
Civil servant 5 (10.0) 3 (6.0)
Others** 7 (14.0) 5 (10.0)
Education, n (%)
Quranic education 3 (6.0) 1 (2.0) χ2=2.38 0.497
Primary education 2 (4.0) 4 (8.0)
Secondary education 19 (38.0) 23 (46.0)
Tertiary education 26 (52.0) 22 (44.0)
*Others - Nupe, Ebira, Kanuri, Ijaw; **Others - banker, hair dresser, tailor; 
SD - Standard deviation
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The maternal satisfaction, as assessed by the Likert scale, 
showed that most of the patients in the two groups were 
somewhat satisfied with the pain relief provided by the 
analgesic that was administered (54.0% in the study group 
and 62.0% in the control group), the difference was not 
statistically significant (P = 0.341). Generally, there were no 
statistically significant differences in the pain perception and 
maternal satisfaction with pain relief in patients between 
the two groups.
Table 4 shows the maternal and the fetal outcome. 
Nausea (P = 0.002), vomiting (P = 0.012), and drowsiness 
(P < 0.001) were significantly higher in the pentazocine 
group when compared with the paracetamol group. None 
of the patients in the two groups developed dyspnea during 
labor, skin rashes, or persistently low systolic blood pressure 
of <90 mmHg, and none had persistent fetal heart rate 
abnormalities during labor or APGAR scores of <7 at the 1st or 
5th min after delivery. However, the mean APGAR score of the 
neonates at 1 min was significantly higher in the paracetamol 
group (P = 0.033), while there was no difference in the mean 
APGAR scores of the neonates in the two groups at 5 min 
after delivery (P = 0.152).
Discussion
In this study, the difference in the pain perception following 
administration of the analgesic during labor between the 
two groups was not statistically significant as shown by 
statistically similar mean VAS scores. This shows that the 
efficacy of IV paracetamol infusion during labor is similar 
to that of IM pentazocine in providing pain relief. Generally, 
there is paucity of studies in which IV paracetamol was 
compared with IM pentazocine for pain relief during labor. 
Table 3: Pain perception and maternal satisfaction with pain relief
Variable Group A (n=50) Group B (n=50) Test P
Mean VAS scores before analgesia (mm) 97.5±4.52 97.6±5.28 t=−0.041 0.968
Mean VAS scores after analgesia (mm) 77.6±10.59 75.3±9.84 t=1.14 0.255
Mean difference in VAS scores (mm) 19.9±9.08 22.3±8.48 t=−1.35 0.179
Maternal satisfaction, n (%)
Somewhat dissatisfied 2 (4.0) 0 χ2=3.35 0.341
Neither dissatisfied or satisfied 11 (22.0) 7 (14.0)
Somewhat satisfied 27 (54.0) 31 (62.0)
Very satisfied 10 (20.0) 12 (24.0)
VAS - Visual analog scale
Table 4: Maternal and fetal outcome
Variable Group A (n=50) Group B (n=50) Test P
Nausea, n (%)
Yes 2 (4.0) 13 (26.0) χ2=9.49 0.002*
No 48 (96.0) 37 (74.0)
Vomiting, n (%)
Yes 0 6 (12.0) Fisher’s exact test 0.012*
No 50 (100.0) 44 (88.0)
Drowsiness, n (%)
Yes 0 17 (34.0) Fisher’s exact test <0.001*
No 50 (100.0) 33 (66.0)
Mean APGAR scores
At 1 min 8.1±0.61 7.8±0.58 t=2.17 0.033*
At 5 min 9.3±0.53 9.1±0.58 t=1.44 0.152
*Statistically significant
Table 2: Obstetric and labor characteristics of patients
Variable Group A (n=50) Group B (n=50) Test P
Mean parity±SD 2.5±1.75 2.3±1.52 t=0.61 0.543
Mean gestational age (weeks) 39.2±1.04 39.3±0.98 t=−0.50 0.621
Median duration of labor and IQR (min) 284.0/5 (257.75-317.00) 284.0 (252.50-320.25) U=1210.00 0.783
Mean EBL (mL) 248.0±74.20 250.0±69.25 t=−0.14 0.889
Mean fetal weight (kg) 3.2±0.24 3.1±0.25 t=0.82 0.415
IQR - Interquartile range; SD - Standard deviation; EBL - Estimated blood loss
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However, other studies have compared the analgesic efficacy 
of IV paracetamol to other opiates or placebo in labor. The 
analgesic efficacy of IV paracetamol infusion in labor has 
been found to be superior to placebo, IM pethidine, and 
tramadol in different studies but comparable to that of IV 
pethidine.[11-14] The analgesic efficacy of IV paracetamol in 
labor was comparable to that of IM pentazocine probably 
because of the pharmacology of IV paracetamol. When 
administered intravenously, its onset of action is 5 min which 
is faster than the 15–20 min for IM pentazocine.[16,17] It also 
has a longer duration of action than IM pentazocine (4–6 h 
compared with 3 h).[16,17] Furthermore, IV administration of 
paracetamol avoids the first-pass effect in the liver and 
leads to higher tissue concentrations of the drug, possibly 
enhancing its analgesic effect.[18]
These drugs reduced pain during labor, but not as much as 
epidural analgesia.[19] Epidural analgesia has the following 
advantages, provides superior pain relief in first and second 
stages of labor, facilitates patient cooperation during 
labor and delivery, provides anesthesia for episiotomy and 
instrumental delivery, allows extension of anesthesia for 
caesarean delivery and avoids opioid-induced maternal and 
neonatal respiratory depression from IV opioids. Besides 
providing analgesia in labor epidural analgesia may facilitate 
atraumatic vaginal delivery of twins, preterm neonates, and 
neonates with breech presentation. It also helps control 
blood pressure in women with preeclampsia by alleviating 
labor pain, and it blunts the hemodynamic effects of uterine 
contractions and the associated pain response in patients 
with other medical complications.[19]
The maternal satisfaction with labor analgesia, as assessed 
by the Likert scale in the two groups, showed no statistically 
significant difference. There is paucity of studies in which 
maternal satisfaction with pain relief in labor was studied 
using IV paracetamol and IM pentazocine. The similar 
maternal satisfaction rates in the two groups obtained in 
this study is in contrast with the findings from a Cochrane 
review, in which maternal satisfaction with labor pain relief 
was compared as a secondary outcome measure between 
opioid and nonopioid analgesics.[20] In that study, women who 
had nonopioid analgesics were less likely to be satisfied with 
pain relief compared with women who had opioids.[20] This 
contrast may be because the majority of studies included 
in that review were conducted over 30 years ago and the 
studies were at unclear risk of bias as noted by the authors 
of the review.[19] Furthermore, the nonopioid analgesics used 
in the studies were nonsteroidal anti-inflammatory drugs, 
and none used IV paracetamol infusion. In both arm of this 
study, significant proportion of the subjects (54% and 62%) 
was somewhat satisfied with the pain relief achieved with the 
IV paracetamol and the IM pentazocine, this implied that the 
efficacy of both agents studied is not excellent.
Maternal nausea, vomiting, and drowsiness all occurred 
more frequently in the pentazocine group than in the 
paracetamol group. None of the patients in either group 
developed dyspnea during labor, skin rashes, or low 
systolic blood pressure below 90 mmHg. This is similar 
to the findings in one study in which IV paracetamol was 
compared with IV pethidine.[12] The study showed 64% of 
the patients in the pethidine group developed maternal 
adverse effects such as vomiting, dizziness, and blurring 
of vision, while none of the patients in the paracetamol 
group developed these complications.[12] In another study, 
maternal adverse effects were compared between patients 
who received IV paracetamol and a placebo, and none of the 
patients who received paracetamol developed any maternal 
adverse effects.[13] The findings from these studies further 
confirmed the safety and tolerability of paracetamol. Other 
studies, however, did not find any significant difference in 
the occurrence of adverse maternal side effects when IV 
paracetamol was used compared with other opiates for labor 
analgesia.[11,14] In one of these studies where IV paracetamol 
and IM pethidine were used, they reported no difference 
in the rate of adverse maternal side effects.[11] This was 
most likely because all patients in that study received IV 
promethazine and IV hyoscine before randomization and 
administration of the analgesic, and this could have reduced 
the incidence of nausea and vomiting in the pethidine group. 
Furthermore, the overall complication rates were reported 
in that study; the incidence of each of the complications was 
not mentioned; and rate of each of these complications were 
not compared between the two groups. Furthermore, the 
study did not report on the rate of dizziness or drowsiness 
among the patients, which could be expected to be higher 
in the pethidine group due to synergistic effect of pethidine 
and pentazocine that could worsen maternal drowsiness, and 
therefore potentially increase the rate of maternal adverse 
effects in the pethidine group. Another study in which IV 
paracetamol was compared with IM tramadol for pain relief 
in labor also reported no significant difference in the rates 
of maternal adverse effects between the two groups.[14] The 
higher incidence of nausea and vomiting in the pentazocine 
group was due to the opiate effect of pentazocine. The exact 
mechanism by which it causes these symptoms is unknown, 
but it is thought to be through direct stimulation of the 
chemoreceptor trigger zone, increased vestibular sensitivity, 
and delayed gastric emptying.[21] Paracetamol does not have 
these effects due to different mechanisms of action.[22-25] 
Furthermore, pentazocine was associated with higher 
incidence of drowsiness because it inhibits the ascending 
pain pathways, which causes alteration in response to pain, 
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producing analgesia, and sedation.[16] Again, paracetamol is 
not associated with sedation due to its different mechanisms 
of action.
None of the fetuses in the two groups developed persistent 
fetal heart rate abnormalities during labor. Furthermore, none 
of the neonates in the two groups had an APGAR score <7 
in the 1st or 5th min after delivery. However, the mean APGAR 
score at 1 min though it was above 7 was significantly lower 
in the pentazocine group than in the paracetamol group. 
There was no significant difference in the mean APGAR 
score of the neonates 5 min after delivery in the two groups. 
This is similar to the findings in a similar study in which IV 
paracetamol and IV pethidine were used.[12] They also found a 
significantly lower mean 1st min APGAR score in the pethidine 
group compared to the paracetamol group, but there was 
no significant difference in the mean 5th min APGAR scores 
between the two groups.[12] Other studies found no difference 
in the mean APGAR scores of the neonates both at 1 min and 
at 5 min between the two groups when IV paracetamol was 
compared with other opiates or placebo.[11,13,14] The 1 min 
APGAR score is a reflection of how well the baby tolerated 
the birthing process and the in utero environment while the 
5 min APGAR score reflects how well the baby is doing after 
birth following resuscitation. Opiates cross the placental 
barrier and can cause respiratory depression in the neonate 
after birth, and this could explain the lower mean 1st min 
APGAR score in the pentazocine group.[6] Paracetamol, though 
it also crosses the placenta barrier, has not been shown to 
have any adverse effect on the fetus when used in standard 
dose in healthy pregnant women at term.[26]
Conclusion
In conclusion, this study showed that the efficacy of IV 
paracetamol was comparable to that of IM pentazocine for 
pain relief during normal labor. Furthermore, the maternal 
satisfaction with pain relief during labor was similar when IV 
paracetamol was compared with IM pentazocine. However, 
IV paracetamol was associated with significantly lower 
maternal adverse effects and significantly higher APGAR 
scores at 1 min after delivery though the APGAR scores at 
5 min after delivery were similar to those obtained following 
administration of IM pentazocine. These findings show that 
IV paracetamol is not only as effective as IM pentazocine in 
providing pain relief in labor but also safer for the mother 
and the baby.
Limitations
Pain perception and maternal satisfaction were difficult 
to measure because they are subjective. Furthermore, 
confounding factors such as maternal anxiety, which could 
have influenced pain perception, could not be controlled for.
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